Circassia Pharmaceuticals Inc is a global leader in point-of-care asthma diagnosis and management, dedicated to improving the quality of life for millions of asthma sufferers worldwide. With their gold standard NIOX device, they provide accurate measurement and monitoring of airway inflammation, helping physicians make informed decisions for better asthma diagnosis and treatment.
With a presence in over 50 countries, Circassia Pharmaceuticals Inc offers exceptional customer support through their dedicated local teams and network of distributors. Their NIOX products have been widely adopted, with millions of FeNO tests completed worldwide, making them the go-to provider for FeNO measurement and monitoring at the point of care.
Generated from the website